-
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub-study
Kerkmeijer, L. S. M., Tijssen, R. Y. G., Hofma, S. H., van der Schaaf, R. J., Arkenbout, E. K., Weevers, A. P. J. D., Kraak, R. P., Onuma, Y., Serruys, P. W., Piek, J. J., Tijssen, J. G. P., Henriques, J. P. S., de Winter, R. J. & Wykrzykowska, J. J., Oct 2021, In: Catheterization and cardiovascular interventions. 98, 4, p. 713-720 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: A sub-analysis of the AIDA trial
Collaborators, Dec 2020, In: EuroIntervention. 16, 11, p. e904-e912Research output: Contribution to journal › Article* › Academic › peer-review
-
The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy
Tijssen, R. Y. G., Kerkmeijer, L. S. M., Takahashi, K., Kogame, N., Katagiri, Y., Kraak, R. P., Chichareon, P., Modolo, R., Asano, T., Nassif, M., Kalkman, D. N., Sotomi, Y., Collet, C., Hofma, S. H., van der Schaaf, R. J., Arkenbout, E. K., Weevers, A. P. J. D., Piek, J. J., Tijssen, J. G. P. & Henriques, J. P. & 4 others, , 1 Apr 2020, In: international journal of cardiovascular imaging. 36, 4, p. 565-575 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
